India has not given permission for use of any vaccine against bird flu nor other countries like the US, UK and the European Union have approved any such vaccine, the government informed Parliament on Friday.
"As per World Organization of Animal Health (OIE), vaccination is not considered the solution for the control of Avian Influenza (Bird Flu) if eradication is the desired result," Union Minister Sanjeev Kumar Balyan said in a written reply to the Rajya Sabha.
Without the application of monitoring systems, strict biosecurity and depopulation in the face of infection, there is a possibility that these viruses could become endemic in vaccinated poultry populations, he said.
Long-term circulation of the virus in a vaccinated population may result in both antigenic and genetic changes in the virus and this has been reported to have occurred in several countries, the Minister of State for Fisheries, Animal Husbandry and Dairying said.
The minister further explained that with the long-term use of vaccination either the disease becomes endemic and therefore widespread, or the infection in affected animals gets too difficult to detect.
"The Government of India has not permitted use of any vaccine against bird flu in the country. Further, it is gathered from the Central Drugs Standards Control Organization (CDSCO) that no such vaccine is approved in countries like the USA, UK, EU etc. to prevent/cure bird flu in birds," he noted.
In a separate reply, the minister said bird flu among commercially reared and wild birds have been confirmed from 14 states and union territories namely Kerala, Haryana, Madhya Pradesh, Maharashtra, Chhattisgarh, Gujarat, Uttar Pradesh, Uttarakhand, Punjab, Himachal Pradesh, Bihar, Rajasthan, Delhi, and Jammu and Kashmir.
So far, the Centre has provided Rs 103.56 crore assistance to these 14 states/union territories for control of bird flu, he added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)